|
MERZ NORTH AMERICA, INC RADIESSE(+) INJECTABLE IMPLANT; IMPLANT, DERMAL, FOR AESTHETIC USE
|
Back to Search Results |
|
| Catalog Number |
8063M0K2 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Obstruction/Occlusion (2422)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The event pain was considered to be a symptom of vascular occlusion and therefore was not coded.This spontaneous report was received from a us health care professional and concerns a 39 year old (1984), female patient.She was injected with radiesse(+), into the chin (off label use of device) on the monday prior to the date of this report.Batch number was reported as a00117960 (expiry date: 06/2025).The batch record review was received and the lot number for radiesse(+) was confirmed as a00117960 (expiry date: 06/2025).A lot search in the global safety database was conducted.After the radiesse(+) injection, the patient experienced possible occlusion in the chin area.The manager stated the patient presented with what appeared to be an occlusion in the chin area, they thought the patient had a vascular occlusion but was not sure.As reported, 12 hours after the injection, the patient experienced pain that traveled to left cheek.On a scale of 1 to 10 the pain was reported as 12.The patient also had pain in her gums.The outcome of the event was unknown.
|
| |
|
Additional Manufacturer Narrative
|
|
This case was assessed as reportable to the fda, as the event possible vascular occlusion (pt: vascular occlusion), was deemed to meet the serious criteria of required intervention to prevent permanent damage.The device history record for radiesse(+) injectable implant, lot number a00117960, was reviewed.A lot search was conducted on the reported lot and no other similar events were noted.No nonconformances were noted related to this lot.
|
| |
|
Search Alerts/Recalls
|
|
|